financetom
Business
financetom
/
Business
/
Cognizant Extends Collaboration With LexisNexis Legal & Professional
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cognizant Extends Collaboration With LexisNexis Legal & Professional
Mar 28, 2024 6:52 AM

09:34 AM EDT, 03/28/2024 (MT Newswires) -- Cognizant (CTSH) said Thursday it has extended a strategic agreement with LexisNexis Legal & Professional, which provides information and analytics.

The company said it will keep providing cloud and digital engineering services to back LexisNexis Legal & Professional's legal research product Lexis+ in the US and Canada.

Financial details about the renewed agreement weren't provided.

Price: 73.3, Change: -0.32, Percent Change: -0.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Moderna Gets FDA Approval for mRESVIA in Adults Aged 18-59 at Increased Risk for RSV Disease
Moderna Gets FDA Approval for mRESVIA in Adults Aged 18-59 at Increased Risk for RSV Disease
Jun 13, 2025
04:44 AM EDT, 06/13/2025 (MT Newswires) -- Moderna ( MRNA ) said late Thursday that the US Food and Drug Administration has approved its mRESVIA vaccine to prevent lower respiratory tract disease caused by respiratory syncytial virus in individuals aged 18 to 59 years who are at increased risk for disease. The vaccine was previously approved for adults aged 60...
GameStop Prices Upsized $2.25 Billion Private Convertible Notes Offering
GameStop Prices Upsized $2.25 Billion Private Convertible Notes Offering
Jun 13, 2025
04:30 AM EDT, 06/13/2025 (MT Newswires) -- GameStop ( GME ) said late Thursday it priced an upsized private offering of $2.25 billion of 0% convertible senior notes due June 15, 2032, for about $2.23 billion in net proceeds. The offering's initial purchaser has an option to acquire up to an additional $450 million of the notes. The company expects...
AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC
AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC
Jun 13, 2025
June 13 (Reuters) - AstraZeneca ( AZN ) said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 billion to focus on AI-enabled initiatives. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved